Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ISAR ADAPT-PF
2011-001686-40Phase 4Completed
- Sponsor
- Deutsches Herzzentrum München
- Start
- Jun 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in atherosclerosis and coronary arteriosclerosis comparing Ticagrelor with Prasugrel (2 arms). Primary endpoint: ADP-induced platelet aggregation on day 2 after randomization. Started Jun 2011; status: completed.
02
Drugs
ticagrelorprasugrel
03
Conditions
atherosclerosiscoronary arteriosclerosis
Beyond the preview
Go deeper on 2011-001686-40.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-001686-40.